CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Celadon Pharmaceuticals PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Celadon Pharmaceuticals PLC
32-33 Cowcross Street
Phone: +44 2031500252p:+44 2031500252 London, EC1M 6DF  United Kingdom Ticker: CELCEL
Business Summary
Celadon Pharmaceuticals Plc is a United Kingdom-based pharmaceutical company. The Company is engaged in the research, cultivation, manufacturing, and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism. The Company is focused on growing indoor hydroponic cannabis initially for the chronic pain market. The Company's facility comprises indoor hydroponic cultivation, proprietary GMP extraction and manufacturing and an analytical and R&D laboratory. It also has a minority interest in early-stage biopharma Kingdom therapeutics. The Company’s products include CEL-F15/0, CEL-F20/0, CEL-F19/0, and Cannabis Oil API. CEL-F15/0 is a meticulously bred cannabis strain deriving from RX11 genetics. CEL-F20/0 is a meticulously bred cannabis strain deriving from Zerberry genetics.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Business Names
Business Name
CEL
SWC

General Information
Outstanding Shares: 68,845,807 (As of 9/17/2024)
Stock Exchange: LON


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, July 15, 2025